In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Flexion Therapeutics, Inc.. Trade Record

NASDAQ:FLXN Flexion Therapeutics, Inc. stock gains 5.97% Exit Sep 1, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart FLXN Aug 22, 2017, priceSeries
About Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Aug 22, 2017
Entry Price
22.89
Sell Date
Sep 1, 2017
Sell Price
24.26
Net Gain
5.97%
Hold Time
8 Trading Days